Tele­health mar­keter Ro pulls its We­govy ad­ver­tis­ing amid on­go­ing sup­ply short­ages

Ro, a tele­health provider that mar­kets a weight loss pro­gram that pre­scribes No­vo Nordisk’s We­govy, is paus­ing some ad­ver­tis­ing for the drug, cit­ing on­go­ing short­ages …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA